Invivyd (IVVD) Long-Term Deferred Tax (2023 - 2025)
Invivyd's (IVVD) quarterly Long-Term Deferred Tax came in at $719000.0 in Q4 2025, down 99.71% YoY from $244.9 million in Q4 2024, and down 99.71% on a QoQ basis from $244.9 million in Q4 2024.
Invivyd (IVVD) Long-Term Deferred Tax (2023 - 2025) Analysis & Trends
Invivyd (IVVD) has 3 years of Long-Term Deferred Tax data on file, last reported at $719000.0 in Q4 2025.
- Quarterly Long-Term Deferred Tax fell 99.71% year-over-year to $719000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $719000.0 (down 99.71% YoY) and the FY2025 annual result came in at $719000.0, down 99.71% from the prior year.
- Long-Term Deferred Tax declined to $719000.0 in Q4 2025, from $244.9 million in the prior quarter.
- In the past five years, Long-Term Deferred Tax ranged from a high of $244.9 million in Q4 2024 to a low of $719000.0 in Q4 2025.
- A 3-year average of $148.9 million and a median of $201.1 million in 2023 frame the typical range for Long-Term Deferred Tax.
- Annual changes were most pronounced in 2024 — Long-Term Deferred Tax grew 21.81% — and 2025, when it sank 99.71%.
- Tracing IVVD's Long-Term Deferred Tax over 3 years: stood at $201.1 million in 2023, then gained by 21.81% to $244.9 million in 2024, then slumped by 99.71% to $719000.0 in 2025.
- The last three Long-Term Deferred Tax figures came in at $719000.0 (Q4 2025), $244.9 million (Q4 2024), and $201.1 million (Q4 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Invivyd | 212.23 Mn | 52.15 Mn | 13.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 719,000.00 |
| Dec 31, 2024 | 244.95 Mn |
| Dec 31, 2023 | 201.08 Mn |